BBN Breaking | LTR Pharma, AFT Pharmaceuticals Make Major Strides in US Healthcare Market

International news network BBN Breaking has reported news of LTR Pharma’s¬†completion of manufacturing validation for SPONTAN this week.

Describing SPONTAN as a “game-changer in Erectile Dysfunction treatment”, the article highlights the significance of meeting all the prerequisites for a pivotal FDA clinical study as the Company prepares to commence patient recruitment for the bioequivalence study.

Click here to read the article.